BRAIN CANCER
Clinical trials for BRAIN CANCER explained in plain language.
Never miss a new study
Get alerted when new BRAIN CANCER trials appear
Sign up with your email to follow new studies for BRAIN CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Lung cancer brain metastasis study halted after just 3 patients
Disease control TerminatedThis study aimed to see if adding the drug pembrolizumab to chemotherapy could help control lung cancer that has spread to the brain without causing new symptoms. It was designed for people with untreated, asymptomatic brain metastases and no specific genetic mutations. However, …
Matched conditions: BRAIN CANCER
Phase: PHASE2 • Sponsor: John L. Villano, MD, PhD • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
Brain cancer drug trial halted after just two patients
Disease control TerminatedThis study tested a new drug called VAL-083 in people with glioblastoma, an aggressive brain cancer, that had come back after standard treatments. The goal was to see if VAL-083 could help patients live longer. However, the trial was stopped early after only 2 people enrolled, so…
Matched conditions: BRAIN CANCER
Phase: PHASE3 • Sponsor: DelMar Pharmaceuticals, Inc. • Aim: Disease control
Last updated May 14, 2026 12:06 UTC
-
Brain tumor study seeks clues in tiny genetic molecules
Knowledge-focused TerminatedThis study looked at a small genetic molecule called microRNA-10b in brain tumor samples from 94 patients. Researchers wanted to see if higher levels of this molecule could help predict how long patients live or how their tumor behaves. They also tested in the lab whether blockin…
Matched conditions: BRAIN CANCER
Sponsor: Dartmouth-Hitchcock Medical Center • Aim: Knowledge-focused
Last updated May 14, 2026 12:04 UTC